PDF

18-May-2023

New Trinity Delta Research Report – Two key Phase II results on track for next 12 months

11-May-2023

New Trinity Delta Lighthouse Report – ROCK solid start in cancer-associated fibrosis

02-Mar-2023

New Trinity Delta Lighthouse Report – Recommended all share combination with Jounce

09-Feb-2023

New Trinity Delta Lighthouse Report – RXC007 recruitment scales up; data now Q124

20-Dec-2022

New Trinity Delta Lighthouse Report – Laying the foundations for further delivery in 2023

07-Oct-2022

New Trinity Delta Research Report – New data draws attention to promising fibrosis assets

29-Jun-2022

New Trinity Delta Research Report – All the ingredients for success now in place

15-Jun-2022

New Trinity Delta Lighthouse Research Report – Jazz Pharmaceuticals $5m milestone triggered

07-Jun-2022

New Trinity Delta Lighthouse Research Report – £34.3m raise extends runway through key data points

30-Mar-2022

New Trinity Delta Research Report – RXC008 nominated as GI-ROCK drug candidate